🇺🇸 FDA
Pipeline program

NIRMATRELVIR, NIRMATRELVIR, Ritonavir, nirmatrelvir / ritonavir

C4671026

Phase 3 small_molecule active

Quick answer

NIRMATRELVIR, NIRMATRELVIR, Ritonavir, nirmatrelvir / ritonavir for SARS-CoV-2 Infection is a Phase 3 program (small_molecule) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).

Program details

Company
Pfizer Ireland Pharmaceuticals Unlimited Company
Indication
SARS-CoV-2 Infection
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials